IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.
I like this bit a lot.
"Our current £80 million weighted orderbook is highly diversified, with work contracted across 7 challenge agents and 11 HCT clients, substantially reducing the impact to hVIVO of potential postponements or cancellations."
Overall a very strong performance. As expected.
Sorry to hear that NST - I hope everything works out for you...
Hi Potnak - I completely agree. And that's a good thing in my opinion...it is good to have liquidity in a share.
And as little as 3 months ago the SP was 5 times the current level. There is a lot of room for upside in the short - and the middle term.
I don't see RF causing any further damage (the damage has already been done).Also, there seems to be a huge appetite for shares at this price so even if they do have more to sell, they'll get snapped up.
The WRAP was almost 4 times oversubscribed, with a very short window and many brokers not engaging.
Hell, even I'm buying - and up until a week ago I though I was watching a slow motion, car-crash that I would never buy back into.
It's tragic that this is the baseline because it really didn't have to be...
However, I do believe it is the baseline and news will send this upwards. Possibly rapidly.
I'm currently wondering what 137,500 shares in the company progressing 737 are actually worth? I've not seen this talked about much here (apologies if I've missed this - I'm not on the boards as much these days) but, given the terms of the previous Sierra agreement, I suspect it isn't peanuts.
“Board will slowly come back to normal”
I sincerely hope not.
Normal service here is removing any critical thinking that is construed as negative by a few long time holders / cheerleaders.
For a company with products as ‘potentially’ good as Sareum, losing this much value is a failure of the business side. Calling this out is not decamping or the domain of shorters.
TAFKAP - Riverfort was a threat to the SP when they were Sareum's only source of funding. That they could continually dilute as the price moved lower. That is no longer the case..
As for their millions of share... Retail investors have just hoovered up 12 million shares in the WRAP. There is a serious appetite at this level so I personally don't see this moving lower anymore.
(And I rather like PUMA. He was spot on about RF)
Very hard to estimate. A savvy board might have only extended the offering if there was enough demand to look impressively oversubscribed... If so I'd go for at least double - maybe even £1million?
I just hope they haven't extended it for a paltry amount of oversubscription.
Me too. I'm starting to (very) cautiously rebuild a position here.
I don't trust the board's ability... or the board itself for that matter. But 737 has proven efficacy and they aren't involved with that anymore. I see it as a hedge against them rat-f*cking the finance anymore or b*llsing up 1801 deal.
If both come good, happy trails.
Are you speaking of efficacy? If 1801 has superior efficacy then the value is huge...
However 1801 hasn't finished phase 1a safety trials yet. And Sareum may not have the funding to put 1801 through a phase 1b / 2a efficacy trial.
This is the issue. Sareum might not have funding to find out if it has a superior product.
It really doesn't matter if it is 'potentially' better - if it doesn't have the money to demonstrate this.
This is why the share price is where it is. This is also why investors are sick of hearing how good it 'might' be, at some point in the future 'if' there's any funding left.
For a UK trial, Would Sareum still need to provide additional data / undergo a review from GLP monitoring authority?
Common sense suggests a successful Phase 1 trial with no serious adverse events would supersede this... But then again, governmental authorities and paperwork...
An almost 20% dilution to raise 1.5 mil.
That's only enough to limp to the end of the year - not enough for a Phase 1b/2a trial.
I don not expect the market to like this at all. It may not happen today - but this is going lower than 10p unless 737 news drops. Utter Joke.
With respect, I would suggest that the biggest threat to Morale is the plummeting SP and the utter silence from the board.
The share price is almost down to ‘pre-consolidation’ high levels (a 50 to 1 consolidation).
Even if Robinhood wasn’t posting - morale would still be in the toilet.
This is an opportunity for Sareum to clarify their position. Will there be an RNS?
You might well be right 'troutisout'. I'd read the line
'for preventing hypercytokinaemia in a patient after an immune response has been triggered' as covering oncology - and the further applications as relating to specific treatment / cancers... But it could equally be your reading of this... Maybe a question for the next presentation? (though possibly one they can't answer in full).
I suspect it will be treated as 'business as usual'...
However, an American patent covering cytokine storm is seriously good news. As Jeremy says - this is a $10billon market for cancer immunotherapy triggered CS alone.
This investor is happy today :-)
Is this the same Tom Winifrith that has co-authored articles with the Riverfort CEO Brian Kinane?
https://www.riverfort.com/post/share-prophets
I keep coming back to this question... and I still cannot answer it.
When the Riverfort funding was announced, 1801 was in the clinic and the share price was £1.
What is it that the board knew, that the shareholders didn't, that the only deal they could get was this one?
(that's where my thinking is... The market Cap at the time was £70million - and they needed to raise £5million. What do the board know, that the shareholders don't, that meant Riverfort was the only option?)
Sunk Cost Fallacy
They won't throw good money after bad either
It appears that Sareum have not been able to renegotiate with RF for the 3rd tranche payment (under a deal where RF can sell 'at any price' to recoup their investment).
1. Is this because Sareum have an alternative investor lined up and they want out?
2. RF think Sareum will go bust?
We know RF could use the SP and number of shares traded to opt out of the arrangement... We don't know if Sareum can (from the detail provided in the RNS.
That's where we are...
Aber - exactly. Either utterly incompetent or going private (in which case SP value will be decimated).
Amazed there hasn’t been a further collapse today after that RNS